TY - JOUR
T1 - Quality assessment of untargeted analytical data in a large-scale metabolomic study
AU - Saito, Rintaro
AU - Sugimoto, Masahiro
AU - Hirayama, Akiyoshi
AU - Soga, Tomoyoshi
AU - Tomita, Masaru
AU - Takebayashi, Toru
N1 - Funding Information:
This study was conducted with partial financial support from the Fondation Nationale pour l'Enseignment de la Gestion des Entreprises (National Foundation for Corporate Management Studies). We wish to acknowledge the helpful comments and suggestions received from Richard R. Lowe, Frances Griffin, and the participants of 10th Asian Pacific Conference on International Accounting Issues.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/5/1
Y1 - 2021/5/1
N2 - Large-scale metabolomic studies have become common, and the reliability of the peak data produced by the various instruments is an important issue. However, less attention has been paid to the large number of uncharacterized peaks in untargeted metabolomics data. In this study, we tested various criteria to assess the reliability of 276 and 202 uncharacterized peaks that were detected in a gathered set of 30 plasma and urine quality control samples, respectively, using capillary electrophoresis-time-of-flight mass spectrometry (CE-TOFMS). The linear relationship between the amounts of pooled samples and the corresponding peak areas was one of the criteria used to select reliable peaks. We used samples from approximately 3000 participants in the Tsuruoka Metabolome Cohort Study to investigate patterns of the areas of these uncharacterized peaks among the samples and clustered the peaks by combining the patterns and differences in the migration times. Our assessment pipeline removed substantial numbers of unreliable or redundant peaks and detected 35 and 74 reliable uncharacterized peaks in plasma and urine, respectively, some of which may correspond to metabolites involved in important physiological processes such as disease progression. We propose that our assessment pipeline can be used to help establish large-scale untargeted clinical metabolomic studies.
AB - Large-scale metabolomic studies have become common, and the reliability of the peak data produced by the various instruments is an important issue. However, less attention has been paid to the large number of uncharacterized peaks in untargeted metabolomics data. In this study, we tested various criteria to assess the reliability of 276 and 202 uncharacterized peaks that were detected in a gathered set of 30 plasma and urine quality control samples, respectively, using capillary electrophoresis-time-of-flight mass spectrometry (CE-TOFMS). The linear relationship between the amounts of pooled samples and the corresponding peak areas was one of the criteria used to select reliable peaks. We used samples from approximately 3000 participants in the Tsuruoka Metabolome Cohort Study to investigate patterns of the areas of these uncharacterized peaks among the samples and clustered the peaks by combining the patterns and differences in the migration times. Our assessment pipeline removed substantial numbers of unreliable or redundant peaks and detected 35 and 74 reliable uncharacterized peaks in plasma and urine, respectively, some of which may correspond to metabolites involved in important physiological processes such as disease progression. We propose that our assessment pipeline can be used to help establish large-scale untargeted clinical metabolomic studies.
KW - Capillary electrophoresis-mass spectrometry
KW - Cohort study
KW - Metabolomics
UR - http://www.scopus.com/inward/record.url?scp=85111988744&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111988744&partnerID=8YFLogxK
U2 - 10.3390/jcm10091826
DO - 10.3390/jcm10091826
M3 - Article
AN - SCOPUS:85111988744
SN - 2077-0383
VL - 10
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 9
M1 - 1826
ER -